Vir Biotechnology stock hits 52-week high at 12.19 USD
Covered in this story
Analyst targets on Vir Biotechnology Inc
- Raymond James: $10.5 → $19 by Sep 2027 · Strong Buy via Investing.com
- H.C. Wainwright: $10.5 → $20 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $VIR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Vir Biotechnology Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.